Educational information, not medical advice — ask your doctor or midwife.
Track Urolithin A with reminders and record whether it helped, in the app.
Urolithin A is a compound produced in your gut when bacteria break down ellagitannins — plant polyphenols found in pomegranates, walnuts, and certain berries. Because gut bacteria vary so widely between people, only about 30–40% of adults naturally produce meaningful amounts of Urolithin A from diet alone. Supplementing it directly bypasses this limitation, delivering consistent levels regardless of your microbiome.
Urolithin A works by activating mitophagy — the body's built-in process for identifying and recycling old, damaged mitochondria so new, healthier ones can take their place. Mitochondria are the tiny power generators inside every cell, and as they age or get damaged, they become less efficient and can cause cellular stress. By keeping the mitochondrial pool cleaner and more functional, Urolithin A helps cells produce energy more effectively, which shows up as better muscle performance and less fatigue.
Urolithin A supplements are most commonly sold as capsules (typically 500–1000 mg) or as flavored powder drink mixes. The most clinically studied commercial form is Mitopure (Timeline Nutrition), a highly pure, standardized UA powder used in human trials. Bioavailability of supplemental UA is consistent and does not depend on gut microbiome composition, unlike dietary precursors.
Urolithin A was identified as a human gut metabolite in the early 2000s, and its link to mitophagy was first established in landmark research around 2016. It represents a relatively new class of postbiotic supplements — compounds your body was always designed to make, but that many people never produce in effective amounts due to microbiome variability.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.